These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13934748)

  • 21. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N; Kaul P; Sehgal R; Gupta I
    Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In response to 'Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole' by Hawkins et al.
    Mensforth S; Goodall L
    Int J STD AIDS; 2016 Jul; 27(8):702-3. PubMed ID: 27278450
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of battery pH readings and electronic pH recordings of the vagina in Trichomonas vaginalis infestation a report of 255 consecutive readings over a period of 143 days in one patient.
    KARNAKY KJ
    Am J Obstet Gynecol; 1959 Jan; 77(1):149-54. PubMed ID: 13606184
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole.
    Hawkins I; Carne C; Sonnex C; Carmichael A
    Int J STD AIDS; 2015 Aug; 26(9):676-8. PubMed ID: 25161176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trichomonas vaginalis infestation in sexually abused girls.
    Jones JG; Yamauchi T; Lambert B
    Am J Dis Child; 1985 Aug; 139(8):846-7. PubMed ID: 3875279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole].
    Dijkmans BA; Polderman AM; Heintz AP; van Furth R
    Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2193-5. PubMed ID: 6983659
    [No Abstract]   [Full Text] [Related]  

  • 28. SYSTEMIC TREATMENT OF TRICHOMONAS VAGINITIS.
    ANDREWS MC; ANDREWS WC
    South Med J; 1963 Nov; 56():1214-8. PubMed ID: 14078366
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental infestation by Trichomonas vaginalis and Paracercobodo hominis in the hypophysectomized female rat. Action of progesterone and testosterone].
    ARON E; COMBESCOT C; DEMARET J; DELCROIX C
    C R Seances Soc Biol Fil; 1959; 153():1439-41. PubMed ID: 13794449
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.
    Tayal S
    Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis.
    Dombrowski MP; Sokol RJ; Brown WJ; Bronsteen RA
    Obstet Gynecol; 1987 Mar; 69(3 Pt 2):524-5. PubMed ID: 3492696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.
    Krajden S; Lossick JG; Wilk E; Yang J; Keystone JS; Elliott K
    CMAJ; 1986 Jun; 134(12):1373-4. PubMed ID: 3486706
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of metronidazole on trichomonas vaginitis in an isolated female population.
    Brochin M; Buxton CL
    N Engl J Med; 1963 Jun; 268():1400-1. PubMed ID: 14015610
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth and life cycle of Trichomonas vaginalis and the mechanism of recurrence of Trichomonas vaginalis vaginitis.
    SHINOZUKA A
    J Jpn Obstet Gynecol Soc; 1955 Jan; 2(1):1-8. PubMed ID: 13252293
    [No Abstract]   [Full Text] [Related]  

  • 36. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TREATMENT OF TRICHOMONAL VAGINITIS WITH IMIDAZOLE DERIVATE].
    SZELL I; EMBER M; NOVAK E
    Magy Noorv Lapja; 1963 Sep; 26():313-20. PubMed ID: 14108627
    [No Abstract]   [Full Text] [Related]  

  • 38. Trichomonas infestation in the male.
    HAMMER JM; PEARSON IA
    Harper Hosp Bull; 1949; 7(6):318-20. PubMed ID: 15397592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the velocity of action of trichomonocidal drugs].
    Broccali G; De Carneri I
    Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
    Malli S; Bories C; Ponchel G; Loiseau PM; Bouchemal K
    Exp Parasitol; 2018 Jun; 189():72-75. PubMed ID: 29730454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.